000 02071cam  2200361zi 4500
0019.944589
003CaOODSP
00520241206084526
006m     o  d f      
007cr cn ||||||||
008241029e202410  onc     ob   f000 0 eng d
020 |a9780660742267
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-383/2024E-PDF
24500|aGuidance on advertising nicotine replacement therapies.
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cOctober 2024.
264 4|c©2024
300 |a1 online resource (iii, 11 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Lignes directrices sur la publicité pour les thérapies de remplacement de la nicotine.
500 |a"Pub.: 240592."
504 |aIncludes bibliographical references (page 11).
520 |a"This guidance document will help industry meet their advertising-related obligations under the Supplementary Rules Respecting Nicotine Replacement Therapies Order (the Order). This document also gives guidance to Health Canada staff on how relevant mandates and objectives should be met fairly, consistently and effectively. Advertising preclearance agencies may use this guidance to inform their internal practices and the services they provide to industry"--Purpose, page 1.
650 0|aSmoking cessation|xLaw and legislation|zCanada.
650 0|aSmoking cessation products|xGovernment policy|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tLignes directrices sur la publicité pour les thérapies de remplacement de la nicotine.|w(CaOODSP)9.944590
85640|qPDF|s434 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-383-2024-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/regulatory-requirements-advertising/policies-guidance-documents/advertising-nicotine-replacement-therapies.html